3,503
Views
28
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Nontuberculous mycobacterial osteomyelitis

, , , , , , , , & show all
Pages 673-685 | Received 29 Sep 2014, Accepted 29 Mar 2015, Published online: 27 Apr 2015

References

  • Shinnick TM, Good RC. Mycobacterial taxonomy. Eur J Clin Microbiol Infect Dis 1994;13:884–901.
  • Falkinham JO 3rd. Nontuberculous mycobacteria in the environment. Clin Chest Med 2002;23:529–51.
  • Chan ED, Kong PM, Fennelly K, Dwyer AP, Iseman MD. Vertebral osteomyelitis due to infection with nontuberculous Mycobacterium species after blunt trauma to the back: 3 examples of the principle of locus minoris resistentiae. Clin Infect Dis 2001;32:1506–10.
  • Zosso C, Lienhard R, Siegrist HH, Malinverni R, Clerc O. Post liposuction infections by rapidly growing mycobacteria. Infect Dis (Lond) 2015;47:69–72.
  • Avery RK, Eavey RD, Della Torre T, Ramos D, Pasternack MS. Bilateral otitis media and mastoiditis caused by a highly resistant strain of Mycobacterium chelonae. Pediatr Infect Dis J 1996;15:1037–40.
  • Yano K, Yoshida T, Minoda Y, Horiki M, Denno K, Yoneda M, et al. Clinical outcome of the chronic flexor tenosynovitis in the hand caused by non-tuberculous mycobacterium treated by extensive tenosynovectomy and drugs. J Plast Surg Hand Surg 2013;47:434–7.
  • Runyon EH. Anonymous mycobacteria in pulmonary disease. Med Clin North Am 1959;43:273–90.
  • Suzuki T, Murai H, Miyakoshi N, Hongo M, Itoi E, Shimada Y. Osteomyelitis of the spine caused by mycobacterium avium complex in an immunocompetent patient. J Orthop Sci 2013;18:490–5.
  • Shimizu H, Mizuno Y, Nakamura I, Fukushima S, Endo K, Matsumoto T. Vertebral osteomyelitis caused by non-tuberculous mycobacteria: case reports and review. J Infect Chemother 2013;19:972–7.
  • Bhatia K, Frydenberg E, Steel T, Ow-Yang M. An anterior expandable titanium cage in Mycobacterium avium vertebral osteomyelitis. J Clin Neurosci 2011;18:431–4.
  • Yazisiz V, Erbasan F, Inan D, Ongut G, Akkaya BK, Alp A, et al. Bone marrow infection caused by Mycobacterium avium complex in a patient with systemic lupus erythematosus. Lupus 2010;19:323–6.
  • Kadzielski J, Smith M, Baran J, Gandhi R, Raskin K. Nontuberculous mycobacterial osteomyelitis: a case report of Mycobacterium avium intracellulare complex tibial osteomyelitis in the setting of HIV/AIDS. Orthop J Harvard Med 2009;11:108–11.
  • Breda L, de Michele G, Nozzi M, De Sanctis S, Di Marzio D, Chiarelli F. Non-tuberculous mycobacterial osteomyelitis: an unusual cause of hip pain in immunocompetent children. Rheumatol Int 2009;29:1487–9.
  • Wong NM, Sun LK, Lau PY. Spinal infection caused by Mycobacterium avium complex in a patient with no acquired immune deficiency syndrome: a case report. J Orthop Surg (Hong Kong) 2008;16:359–63.
  • Kahlon SS, East JW, Sarria JC. Mycobacterium-avium-intracellulare complex immune reconstitution inflammatory syndrome in HIV/AIDS presenting as osteomyelitis. AIDS Read 2008;18:515–18.
  • Hirakawa A, Miyamoto K, Ohno Y, Hioki A, Ogawa H, Nishimoto H, et al. Two-stage (posterior and anterior) surgical treatment of spinal osteomyelitis due to atypical mycobacteria and associated thoracolumbar kyphoscoliosis in a nonimmunocompromised patient. Spine 2008;33:E221–4.
  • Muller B, Kemper J, Hartwig NG, Mooi-Kokenberg EA, van Altena R, Versteegh FG. Mycobacterium avium intracellulare otomastoiditis: case report and literature review. Eur J Clin Microbiol Infect Dis 2006;25:723–7.
  • Corrales-Medina V, Symes S, Valdivia-Arenas M, Boulanger C. Localized Mycobacterium avium complex infection of vertebral and paravertebral structures in an HIV patient on highly active antiretroviral therapy. South Med J 2006;99:174–7.
  • Mehta JB, Emery MW, Girish M, Byrd RP Jr, Roy TM. Atypical Pott's disease: localized infection of the thoracic spine due to Mycobacterium avium-intracellulare in a patient without human immunodeficiency virus infection. South Med J 2003;96:685–8.
  • Niazi S, Batra V, Zangrilli JG. Atypical mycobacterial osteomyelitis in a non-AIDS patient. Conn Med 2002;66:387–9.
  • Aberg JA, Chin-Hong PV, McCutchan A, Koletar SL, Currier JS. Localized osteomyelitis due to Mycobacterium avium complex in patients with Human Immunodeficiency Virus receiving highly active antiretroviral therapy. Clin Infect Dis 2002;35:E8–E13.
  • Arend SM, Janssen R, Gosen JJ, Waanders H, de Boer T, Ottenhoff TH, et al. Multifocal osteomyelitis caused by nontuberculous mycobacteria in patients with a genetic defect of the interferon-gamma receptor. Neth J Med 2001;59:140–51.
  • Weigl JA, Haas WH. Postoperative Mycobacterium avium osteomyelitis confirmed by polymerase chain reaction. Eur J Pediatr 2000;159:64–9.
  • Frosch M, Roth J, Ullrich K, Harms E. Successful treatment of Mycobacterium avium osteomyelitis and arthritis in a non-immunocompromised child. Scand J Infect Dis 2000;32:328–9.
  • Flint D, Mahadevan M, Gunn R, Brown S. Nontuberculous mycobacterial otomastoiditis in children: four cases and a literature review. Int J Pediatr Otorhinolaryngol 1999;51: 121–7.
  • Weiner BK, Love TW, Fraser RD. Mycobacterium avium intracellulare: vertebral osteomyelitis. J Spinal Disord 1998; 11:89–91.
  • Pombo D, Woods ML 2nd, Burgert SJ, Shumsky IB, Reimer LG. Disseminated Mycobacterium avium complex infection presenting as osteomyelitis in a normal host. Scand J Infect Dis 1998;30:622–3.
  • Sheppard DC, Sullam PM. Primary septic arthritis and osteomyelitis due to Mycobacterium avium complex in a patient with AIDS. Clin Infect Dis 1997;25:925–6.
  • Igram CM, Petrie SG, Harris MB. Atypical mycobacterial vertebral osteomyelitis in an immunocompetent patient. Orthopedics 1997;20:163–6.
  • Di Rocco M, Tasso L, Fondelli MP, Marino C, Romanengo M, Giacchino R, et al. Case of the month: a child with stiff neck. Eur J Pediatr 1997;156:737–8.
  • Weingardt JP, Kilcoyne RF, Russ PD, Johnston RJ, Nawaz S. Disseminated Mycobacterium avium complex presenting with osteomyelitis of the distal femur and proximal tibia. Skeletal Radiol 1996;25:193–6.
  • Kourtis AP, Ibegbu CC, Snitzer JA, Nesheim SR. Recurrent multifocal osteomyelitis due to Mycobacterium avium complex. Clin Infect Dis 1996;23:1194–5.
  • Hirsch R, Miller SM, Kazi S, Cate TR, Reveille JD. Human immunodeficiency virus-associated atypical mycobacterial skeletal infections. Semin Arthritis Rheum 1996; 25:347–56.
  • Mahan S, Jolles PR. MAI osteomyelitis. 18-Year scintigraphic follow-up. Clin Nucl Med 1995;20:594–8.
  • Jones AR, Bartlett J, McCormack JG. Mycobacterium avium complex (MAC) osteomyelitis and septic arthritis in an immunocompetent host. J Infect 1995;30:59–62.
  • Gallant JE, Alwood K, Chaisson RE. Osteomyelitis due to Mycobacterium kansasii and Mycobacterium avium complex in an HIV-infected patient. Infect Dis Clin Pract 1994;3:297–99.
  • Raszka WV Jr, Trinh TT, Zawadsky PM. Multifocal M. intracellulare osteomyelitis in an immunocompetent child. Clin Pediatr (Phila) 1994;33:611–16.
  • Tanaka M, Matsui H, Tsuji H. Atypical mycobacterium osteomyelitis of the fibula. Int Orthop 1993;17:48–50.
  • Pirofsky JG, Huang CT, Waites KB. Spinal osteomyelitis due to Mycobacterium avium-intracellulare in an elderly man with steroid-induced osteoporosis. Spine (Phila Pa 1976) 1993;18:1926–9.
  • Blumenthal DR, Zucker JR, Hawkins CC. Mycobacterium avium complex-induced septic arthritis and osteomyelitis in a patient with the acquired immunodeficiency syndrome. Arthritis Rheum 1990;33:757–8.
  • Namey TC, Frogameni AD. Coexistent Mycobacterium intracellulare gonarthritis and patellar osteomyelitis in a patient with pulmonary sarcoidosis. A case report and literature review. Orthopedics 1986;9:425–30.
  • Collert S, Petrini B, Wickman K. Osteomyelitis caused by Mycobacterium avium. Acta Orthop Scand 1983;54:449–51.
  • Cohen RJ, Samoszuk MK, Busch D, Lagios M. Occult infections with M. intracellulare in bone-marrow biopsy specimens from patients with AIDS. N Engl J Med 1983; 308:1475–6.
  • Zvetina JR, Demos TC, Rubinstein H. Mycobacterium intracellulare infection of the shoulder and spine in a patient with steroid-treated systemic lupus erythematosus. Skeletal Radiol 1982;8:111–13.
  • Solheim LF, Kjelsberg F. Recurrent mycobacterial osteomyelitis. Report of a case due to Mycobacterium avium-intracellulare-scrofulaceum complex and BCG vaccination. Arch Orthop Trauma Surg 1982;100:277–80.
  • Bolvig L, Andresen J. Osteomyelitis due to Mycobacterium intracellulare. Pediatr Radiol 1981;10:241–3.
  • Bender BL, Yunis EJ. Disseminated nongranulomatous Mycobacterium avium osteomyelitis. Hum Pathol 1980; 11:476–8.
  • Jenkin DJ, Dall G. Lesions of bone in disseminated infection due to the Mycobacterium avium-intracellulare group. Report of a case. J Bone Joint Surg Br 1975;57:373–5.
  • Hu LB. Mycobacterium ulcerans osteomyelitis: a closer look at the x-ray films. N Engl J Med 1996;335:1771–2.
  • Weed HG. Mycobacterium ulcerans and osteomyelitis. N Engl J Med 1993;329:582; author reply 3.
  • Hofer M, Hirschel B, Kirschner P, Beghetti M, Kaelin A, Siegrist CA, et al. Brief report: disseminated osteomyelitis from Mycobacterium ulcerans after a snakebite. N Engl J Med 1993;328:1007–9.
  • Sivan M, Bose D, Athanasou N, McNally M. Mycobacterium marinum osteomyelitis of a long bone. Joint Bone Spine 2008;75:600–2.
  • Wilson KC, Bielska B, Farber HW. Mycobacterium marinum osteomyelitis. Orthopedics 2003;26:331–2.
  • Shih JY, Hsueh PR, Chang YL, Chen MT, Yang PC, Luh KT. Osteomyelitis and tenosynovitis due to Mycobacterium marinum in a fish dealer. J Formos Med Assoc 1997;96:913–16.
  • Barton A, Bernstein RM, Struthers JK, O’Neill TW. Mycobacterium marinum infection causing septic arthritis and osteomyelitis. Br J Rheumatol 1997;36:1207–9.
  • Clark RB, Spector H, Friedman DM, Oldrati KJ, Young CL, Nelson SC. Osteomyelitis and synovitis produced by Mycobacterium marinum in a fisherman. J Clin Microbiol 1990;28:2570–2.
  • Kamel G, Youssef M, Haidar R, Khater B, Kanafani ZA. Osteomyelitis at two noncontiguous sites caused by Mycobacterium marinum in an immunocompetent host: case report and literature review. J Med Liban 2014; 62:180–2.
  • Williams B, Neth O, Shingadia D, Dixon G, Jupp RS, Rosendahl K, et al. Mycobacterium kansasii causing septic arthritis and osteomyelitis in a child. Pediatr Infect Dis J 2010;29:88–9.
  • Yano T, Okuda S, Kato K, Kato K, Kishimoto T. Mycobacterium kansasii osteomyelitis in a patient with AIDS on highly active antiretroviral therapy. Intern Med 2004;43:1084–6.
  • Schnadig VJ, Quadri SF, Boyvat F, Borucki M. Mycobacterium kansasii osteomyelitis presenting as a solitary lytic lesion of the ulna: fine-needle aspiration findings and morphologic comparison with other mycobacteria. Diagn Cytopathol 1998;19:94–7.
  • Capdevila O, Zurita A, Domingo E, Corbella X, Alcaide F, Monfort JL, et al. Multiple cranial osteolytic lesions due to Mycobacterium kansasii in a patient with AIDS. Scand J Infect Dis 1998;30:305–6.
  • Minkin BI, Mills CL, Bullock DW, Burke FD. Mycobacterium kansasii osteomyelitis of the scaphoid. J Hand Surg Am 1987;12:1092–4.
  • Bakhsh WR, Mesfin A. Mycobacterium kansasii infection of the spine in a patient with sarcoidosis: a case report and literature review. J Surg Orthop Adv 2014;23:162–5.
  • Kulasegaram R, Richardson D, Macrae B, de Ruiter A. Mycobacterium xenopi osteomyelitis in a patient on highly active antiretroviral therapy (HAART). Int J STD AIDS 2001;12:404–6.
  • Danesh-Clough T, Theis JC, van der Linden A. Mycobacterium xenopi infection of the spine: a case report and literature review. Spine (Phila Pa 1976) 2000;25:626–8.
  • Clark JE, Abinun M, Flood TJ, Cant AJ. Mycobacterium xenopi osteomyelitis. Pediatr Infect Dis J 1997;16:1011.
  • Molloy J, Shandilya M, Mahesh B, McShane D, El Nazir B. One to make the diagnosis. A case of non tuberculous mycobacterial mastoiditis in a nine year old female. Ir Med J 2008;101:123–4.
  • Elsayed S, Read R. Mycobacterium haemophilum osteomyelitis: case report and review of the literature. BMC Infect Dis 2006;6:70.
  • Plemmons RM, McAllister CK, Garces MC, Ward RL. Osteomyelitis due to Mycobacterium haemophilum in a cardiac transplant patient: case report and analysis of interactions among clarithromycin, rifampin, and cyclosporine. Clin Infect Dis 1997;24:995–7.
  • Phoa LL, Khong KS, Thamboo TP, Lam KN. A case of Mycobacterium scrofulaceum osteomyelitis of the right wrist. Ann Acad Med Singapore 2000;29:678–81.
  • Meyer JJ, Gelman SS. Multifocal osteomyelitis due to Mycobacterium szulgai in a patient with chronic lymphocytic leukemia. J Infect 2008;56:151–4.
  • Tappe D, Langmann P, Zilly M, Klinker H, Schmausser B, Frosch M. Osteomyelitis and skin ulcers caused by Mycobacterium szulgai in an AIDS patient. Scand J Infect Dis 2004;36:883–5.
  • Luque AE, Kaminski D, Reichman R, Hardy D. Mycobacterium szulgai osteomyelitis in an AIDS patient. Scand J Infect Dis 1998;30:88–91.
  • Hurr H, Sorg T. Mycobacterium szulgai osteomyelitis. J Infect 1998;37:191–2.
  • Hong SK, Sung JY, Lee HJ, Oh MD, Park SS, Kim EC. First case of Mycobacterium longobardum infection. Ann Lab Med 2013;33:356–9.
  • Mastroianni A. Mycobacterium flavescens vertebral osteomyelitis in an immunocompetent host. Infez Med 2003;11:97–101.
  • Bar T, Mishal J, Lewkowicz A, Nahlieli O. Osteomyelitis of the mandible due to Mycobacterium abscessus: a case report. J Oral Maxillofac Surg 2005;63:841–4.
  • Kato S, Murakami H, Demura S, Yoshioka K, Hayashi H, Yokogawa N, et al. Vertebral osteomyelitis caused by Mycobacterium abscessus surgically treated using antibacterial iodine-supported instrumentation. Case Rep Orthop 2014;2014:4.
  • Sarria JC, Chutkan NB, Figueroa JE, Hull A. Atypical mycobacterial vertebral osteomyelitis: case report and review. Clin Infect Dis 1998;26:503–5.
  • Meredith FT, Sexton DJ. Mycobacterium abscessus osteomyelitis following a plantar puncture wound. Clin Infect Dis 1996;23:651–3.
  • Pruitt TC, Hughes LO, Blasier RD, McCarthy RE, Glasier CM, Roloson GJ. Atypical mycobacterial vertebral osteomyelitis in a steroid-dependent adolescent. A case report. Spine (Phila Pa 1976) 1993;18:2553–5.
  • McAvoy MJ, Carron MA, Poulik J, Altinok D, Belenky W. Sequelae of rapid growing mycobacteria otomastoiditis in a child. Arch Otolaryngol Head Neck Surg 2009;135:602–4.
  • Kwan K, Ho ST. Mycobacterium chelonae and Mycobacterium fortuitum infection following open fracture: a case report and review of the literature. Indian J Med Microbiol 2010;28:248–50.
  • Satti L, Abbasi S, Sattar A, Ikram A, Manzar MA, Khalid MM. Bone marrow infection with Mycobacterium fortuitum in a diabetic patient. J Coll Physicians Surg Pak 2011;21:500–2.
  • Cruz AT, Antekeier SB. Chronic multifocal Mycobacterium fortuitum osteomyelitis following penetrating plantar trauma. Am J Orthop (Belle Mead NJ) 2012;41:E109–11.
  • Longardner K, Allen A, Ramgopal M. Spinal osteomyelitis due to Mycobacterium fortuitum in a former intravenous drug user. BMJ Case Rep 2013;2013.
  • Lazzarini L, Amina S, Wang J, Calhoun JH, Mader JT. Mycobacterium tuberculosis and Mycobacterium fortuitum osteomyelitis of the foot and septic arthritis of the ankle in an immunocompetent patient. Eur J Clin Microbiol Infect Dis 2002;21:468–70.
  • Tejan-Sie SA, Avery RK, Mossad SB. Mycobacterium fortuitum osteomyelitis in a peripheral blood stem cell transplant recipient. Scand J Infect Dis 2000;32:94–6.
  • Miron D, El AL, Zuker M, Lumelsky D, Murph M, Floyd MM, et al. Mycobacterium fortuitum osteomyelitis of the cuboid after nail puncture wound. Pediatr Infect Dis J 2000;19:483–5.
  • Gadre DV. HIV associated chronic atypical osteomyelitis by Mycobacterium fortuitum—Chelonae group – a case report. Indian J Med Sci 1997;51:161–3.
  • Samuels LE, Sharma S, Morris RJ, Solomon MP, Granick MS, Wood CA, et al. Mycobacterium fortuitum infection of the sternum. Review of the literature and case illustration. Arch Surg 1996;131:1344–6.
  • Plemmons RM, McAllister CK, Liening DA, Garces MC. Otitis media and mastoiditis due to Mycobacterium fortuitum: case report, review of four cases, and a cautionary note. Clin Infect Dis 1996;22:1105–6.
  • Goodhart GL. Mycobacterium fortuitum osteomyelitis following trauma. J Orthop Trauma 1993;7:142–5.
  • Hasegawa T, Watanabe R, Hayashi K, Inufusa A, Nakagawa H. Postoperative osteomyelitis due to Mycobacterium fortuitum. A case report. Arch Orthop Trauma Surg 1992;111:178–80.
  • Iyengar KP, Nadkarni JB, Gupta R, Beeching NJ, Ullah I, Loh WY. Mycobacterium chelonae hand infection following ferret bite. Infection 2013;41:237–41.
  • Wu KC, Shu MT, Chen BN. Otomastoiditis with acute left facial nerve paralysis caused by Mycobacterium chelonae. Ear Nose Throat J 2011;90:E18–22.
  • Rahman I, Bhatt H, Chillag S, Duffus W. Mycobacterium chelonae vertebral osteomyelitis. South Med J 2009;102: 1167–9.
  • Mullin D, Jothi S, Healy D. Mycobacterium chelonae infections involving the head and neck. Ann Otol Rhinol Laryngol 2009;118:714–20.
  • Korres DS, Papagelopoulos PJ, Zahos KA, Kolia MD, Poulakou GG, Falagas ME. Multifocal spinal and extra-spinal Mycobacterium chelonae osteomyelitis in a renal transplant recipient. Transpl Infect Dis 2007;9: 62–5.
  • Kim RS, Kim JS, Choi DH, Kwon DS, Jung JH. M. chelonae soft tissue infection spreading to osteomyelitis. Yonsei Med J 2004;45:169–73.
  • Gollwitzer H, Langer R, Diehl P, Mittelmeier W. Chronic osteomyelitis due to Mycobacterium chelonae diagnosed by polymerase chain reaction homology matching. A case report. J Bone Joint Surg Am 2004;86-A:1296–301.
  • Wilson S, Cascio B, Neitzschman HR. Radiology case of the month. Nail puncture wound to the foot. Mycobacterium chelonei osteomyelitis. J La State Med Soc 1999;151:251–2.
  • van Aarem A, Muytjens HL, Smits MM, Cremers CW. Recurrent therapy resistant mastoiditis by Mycobacterium cheilonae abscessus, a nontuberculous mycobacterium. Int J Pediatr Otorhinolaryngol 1998;43:61–72.
  • Thordarson DB, Patzakis MJ, Holtom P, Sherman R. Salvage of the septic ankle with concomitant tibial osteomyelitis. Foot Ankle Int 1997;18:151–6.
  • Brown BA, Springer B, Steingrube VA, Wilson RW, Pfyffer GE, Garcia MJ, et al. Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. Int J Syst Bacteriol 1999;49(Pt 4): 1493–511.
  • Suy F, Carricajo A, Grattard F, Cazorla C, Denis C, Girardin P, et al. Infection due to Mycobacterium thermoresistibile: a case associated with an orthopedic device. J Clin Microbiol 2013;51:3154–6.
  • van Ingen J, Looijmans F, Mirck P, Dekhuijzen R, Boeree M, van Soolingen D. Otomastoiditis caused by Mycobacterium abscessus, The Netherlands. Emerg Infect Dis 2010;16:166–8.
  • Marazzi MG, Chapgier A, Defilippi AC, Pistoia V, Mangini S, Savioli C, et al. Disseminated Mycobacterium scrofulaceum infection in a child with interferon-gamma receptor 1 deficiency. Int J Infect Dis 2010;14:e167–70.
  • Frehel C, Ryter A, Rastogi N, David H. The electron- transparent zone in phagocytized Mycobacterium avium and other mycobacteria: formation, persistence and role in bacterial survival. Ann Inst Pasteur Microbiol 1986; 137B:239–57.
  • Kawabata Y, Semba I, Hirayama Y, Koga T, Nagao S, Takada H. Wax D of Mycobacterium tuberculosis induced osteomyelitis accompanied by reactive bone formation in Buffalo rats. FEMS Immunol Med Microbiol 1998;22:293–302.
  • Broutin V, Banuls AL, Aubry A, Keck N, Choisy M, Bernardet JF, et al. Genetic diversity and population structure of Mycobacterium marinum: new insights into host and environmental specificities. J Clin Microbiol 2012; 50:3627–34.
  • Tsai LT, Wang CY, Lin CD, Tsai MH. Nontuberculous mycobacterial otomastoiditis: a case report. Ear Nose Throat J 2013;92:31–3.
  • Portaels F, Aguiar J, Debacker M, Guedenon A, Steunou C, Zinsou C, et al. Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease. Infect Immun 2004;72:62–5.
  • Scherr N, Muller P, Perisa D, Combaluzier B, Jeno P, Pieters J. Survival of pathogenic mycobacteria in macrophages is mediated through autophosphorylation of protein kinase G. J Bacteriol 2009;191:4546–54.
  • Jayachandran R, Sundaramurthy V, Combaluzier B, Mueller P, Korf H, Huygen K, et al. Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. Cell 2007;130:37–50.
  • Corti A, Fattorini L, Thoresen OF, Ricci ML, Gallizia A, Pelagi M, et al. Upregulation of p75 tumor necrosis factor alpha receptor in Mycobacterium avium-infected mice: evidence for a functional role. Infect Immun 1999; 67:5762–7.
  • Chambers TJ, Fox S, Jagger CJ, Lean JM, Chow JW. The role of prostaglandins and nitric oxide in the response of bone to mechanical forces. Osteoarthritis Cartilage 1999; 7:422–3.
  • Fox SW, Chambers TJ, Chow JW. Nitric oxide is an early mediator of the increase in bone formation by mechanical stimulation. Am J Physiol 1996;270:E955–60.
  • Wimalawansa SJ. Nitric oxide and bone. Ann N Y Acad Sci 2010;1192:391–403.
  • Turner CH, Owan I, Jacob DS, McClintock R, Peacock M. Effects of nitric oxide synthase inhibitors on bone formation in rats. Bone 1997;21:487–90.
  • Petitjean G, Fluckiger U, Scharen S, Laifer G. Vertebral osteomyelitis caused by non-tuberculous mycobacteria. Clin Microbiol Infect 2004;10:951–3.
  • Levin M, Newport MJ, D’Souza S, Kalabalikis P, Brown IN, Lenicker HM, et al. Familial disseminated atypical mycobacterial infection in childhood: a human mycobacterial susceptibility gene? Lancet 1995;345:79–83.
  • D’Souza S, Levin M, Faith A, Yssel H, Bennett B, Lake RA, et al. Defective antigen processing associated with familial disseminated mycobacteriosis. Clin Exp Immunol 1996; 103:35–9.
  • Bermudez LE, Wu M, Young LS. Interleukin-12-stimulated natural killer cells can activate human macrophages to inhibit growth of Mycobacterium avium. Infect Immun 1995;63:4099–104.
  • Doherty TM, Sher A. IL-12 promotes drug-induced clearance of Mycobacterium avium infection in mice. J Immunol 1998;160:5428–35.
  • Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med 2012;367:725–34.
  • Casanova JL. IL-12 and IFN-γ in host defense against mycobacteria and salmonella in mice and men. Curr Opin Immunol 1999;11:346–51.
  • Rottman M, Catherinot E, Hochedez P, Emile JF, Casanova JL, Gaillard JL, et al. Importance of T cells, gamma interferon, and tumor necrosis factor in immune control of the rapid grower Mycobacterium abscessus in C57BL/6 mice. Infect Immun 2007;75:5898–907.
  • Feng CG, Kullberg MC, Jankovic D, Cheever AW, Caspar P, Coffman RL, et al. Transgenic mice expressing human interleukin-10 in the antigen-presenting cell compartment show increased susceptibility to infection with Mycobacterium avium associated with decreased macrophage effector function and apoptosis. Infect Immun 2002;70:6672–9.
  • Silva RA, Florido M, Appelberg R. Interleukin-12 primes CD4 + T cells for interferon-gamma production and protective immunity during Mycobacterium avium infection. Immunology 2001;103:368–74.
  • Newport MJ, Huxley CM, Huston S, Hawrylowicz CM, Oostra BA, Williamson R, et al. A mutation in the interferon-gamma-receptor gene and susceptibility to mycobacterial infection. N Engl J Med 1996;335:1941–9.
  • Dupuis S, Doffinger R, Picard C, Fieschi C, Altare F, Jouanguy E, et al. Human interferon-gamma-mediated immunity is a genetically controlled continuous trait that determines the outcome of mycobacterial invasion. Immunol Rev 2000;178:129–37.
  • Hoflich C, Sabat R, Rosseau S, Temmesfeld B, Slevogt H, Docke WD, et al. Naturally occurring anti-IFN-gamma autoantibody and severe infections with Mycobacterium cheloneae and Burkholderia cocovenenans. Blood 2004;103: 673–5.
  • Dorman SE, Picard C, Lammas D, Heyne K, van Dissel JT, Baretto R, et al. Clinical features of dominant and recessive interferon gamma receptor 1 deficiencies. Lancet 2004;364:2113–21.
  • Browne SK, Holland SM. Immunodeficiency secondary to anticytokine autoantibodies. Curr Opin Allergy Clin Immunol 2010;10:534–41.
  • Adams LV, Waddell RD, Von Reyn CF. T-SPOT.TB Test(R) results in adults with Mycobacterium avium complex pulmonary disease. Scand J Infect Dis 2008;40:196–203.
  • Hermansen TS, Thomsen VO, Lillebaek T, Ravn P. Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark. PLoS One 2014;9:e93986.
  • Detjen AK, Keil T, Roll S, Hauer B, Mauch H, Wahn U, et al. Interferon-gamma release assays improve the diagnosis of tuberculosis and nontuberculous mycobacterial disease in children in a country with a low incidence of tuberculosis. Clin Infect Dis 2007;45:322–8.
  • Minematsu A, Sawai T, Matsutake T, Soejima Y, Naito S, Kohno S. [A case of Mycobacterium intracellulare pulmonary infection with vertebral osteomyelitis.] Kansenshogaku Zasshi 2011;85:527–31 (in Japanese).
  • Meyers SP, Wiener SN. Diagnosis of hematogenous pyogenic vertebral osteomyelitis by magnetic resonance imaging. Arch Intern Med 1991;151:683–7.
  • Herlin T, Thelle T, Kragballe K, Borregaard N, Thestrup-Pedersen K. Sustained depression of monocyte cytotoxicity in a boy with disseminated nontuberculous mycobacteriosis. J Pediatr 1981;99:264–7.
  • Marchevsky AM, Damsker B, Green S, Tepper S. The clinicopathological spectrum of non-tuberculous mycobacterial osteoarticular infections. J Bone Joint Surg Am 1985; 67:925–9.
  • Robicsek F, Hoffman PC, Masters TN, Daugherty HK, Cook JW, Selle JG, et al. Rapidly growing nontuberculous mycobacteria: a new enemy of the cardiac surgeon. Ann Thorac Surg 1988;46:703–10.
  • Smith MB, Molina CP, Schnadig VJ, Boyars MC, Aronson JF. Pathologic features of Mycobacterium kansasii infection in patients with acquired immunodeficiency syndrome. Arch Pathol Lab Med 2003;127:554–60.
  • von Graevenitz A, Punter-Streit V. Failure to recognize rapidly growing mycobacteria in a proficiency testing sample without specific request – a wider diagnostic problem? Eur J Epidemiol 1998;14:519–20.
  • Pommelet V, Vincent QB, Ardant MF, Adeye A, Tanase A, Tondeur L, et al. Findings in patients from Benin with osteomyelitis and polymerase chain reaction-confirmed Mycobacterium ulcerans infection. Clin Infect Dis 2014;59:1256–64.
  • Torriani FJ, Behling CA, McCutchan JA, Haubrich RH, Havlir DV. Disseminated Mycobacterium avium complex: correlation between blood and tissue burden. J Infect Dis 1996;173:942–9.
  • Gupta S, Cohen KA, Winglee K, Maiga M, Diarra B, Bishai WR. Efflux inhibition with verapamil potentiates bedaquiline in Mycobacterium tuberculosis. Antimicrob Agents Chemother 2014;58:574–6.
  • Chahine EB, Karaoui LR, Mansour H. Bedaquiline: a novel diarylquinoline for multidrug-resistant tuberculosis. Ann Pharmacother 2014;48:107–15.
  • Ispahani P, Baker M. Mycobacterial culture: how long? Lancet 1988;1:305.
  • Wallace RJ Jr, Swenson JM, Silcox VA, Bullen MG. Treatment of nonpulmonary infections due to Mycobacterium fortuitum and Mycobacterium chelonei on the basis of in vitro susceptibilities. J Infect Dis 1985;152:500–14.
  • Ingram CW, Tanner DC, Durack DT, Kernodle GW Jr, Corey GR. Disseminated infection with rapidly growing mycobacteria. Clin Infect Dis 1993;16:463–71.
  • Chow SP, Ip FK, Lau JH, Collins RJ, Luk KD, So YC, et al. Mycobacterium marinum infection of the hand and wrist. Results of conservative treatment in twenty-four cases. J Bone Joint Surg Am 1987;69:1161–8.
  • Bhagat N, Read RW, Rao NA, Smith RE, Chong LP. Rifabutin-associated hypopyon uveitis in human immunodeficiency virus-negative immunocompetent individuals. Ophthalmology 2001;108:750–2.
  • Lee J, Armstrong DT, Ssengooba W, Park JA, Yu Y, Mumbowa F, et al. Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs. Antimicrob Agents Chemother 2014;58:11–18.
  • Portaels F, Aguiar J, Debacker M, Steunou C, Zinsou C, Guedenon A, et al. Prophylactic effect of Mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli ulcer). Clin Diagn Lab Immunol 2002;9:1389–91.
  • Grange JM. Mycobacterium bovis infection in human beings. Tuberculosis (Edinb) 2001;81:71–7.
  • Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007;175:367–416.
  • Nightingale SD, Cameron DW, Gordin FM, Sullam PM, Cohn DL, Chaisson RE, et al. Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in AIDS. N Engl J Med 1993;329:828–33.
  • Scharfstein JA, Paltiel AD, Weinstein MC, Seage GR, Losina E, Craven DE, et al. The cost-effectiveness of prophylaxis for Mycobacterium avium complex in AIDS. Int J Technol Assess Health Care 1999;15:531–47.
  • Good RC. Opportunistic pathogens in the genus Mycobacterium. Annu Rev Microbiol 1985;39:347–69.
  • Benson CA. Disease due to the Mycobacterium avium complex in patients with AIDS: epidemiology and clinical syndrome. Clin Infect Dis 1994;18(Suppl 3):S218–22.
  • Straus WL, Ostroff SM, Jernigan DB, Kiehn TE, Sordillo EM, Armstrong D, et al. Clinical and epidemiologic characteristics of Mycobacterium haemophilum, an emerging pathogen in immunocompromised patients. Ann Intern Med 1994;120:118–25.
  • McNaghten AD, Adams MR, Dworkin MS. Case 23-2000: osteomyelitis in HIV-infected patients. N Engl J Med 2001;344:66–7.
  • Appelberg R, Castro AG, Pedrosa J, Silva RA, Orme IM, Minoprio P. Role of gamma interferon and tumor necrosis factor alpha during T-cell-independent and -dependent phases of Mycobacterium avium infection. Infect Immun 1994;62:3962–71.
  • Wallace RJ Jr, Brown BA, Onyi GO. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin. J Infect Dis 1992;166:405–12.
  • Skowronski M, Zozulinska-Ziolkiewicz D, Barinow-Wojewodzki A. Tuberculosis and diabetes mellitus – an underappreciated association. Arch Med Sci 2014;10:1019–27.
  • Tsiavou A, Degiannis D, Hatziagelaki E, Koniavitou K, Raptis SA. Intracellular IFN-gamma production and IL-12 serum levels in latent autoimmune diabetes of adults (LADA) and in type 2 diabetes. J Interferon Cytokine Res 2004;24:381–7.
  • Faurholt-Jepsen D, Aabye MG, Jensen AV, Range N, Praygod G, Jeremiah K, et al. Diabetes is associated with lower tuberculosis antigen-specific interferon gamma release in Tanzanian tuberculosis patients and non-tuberculosis controls. Scand J Infect Dis 2014;46:384–91.
  • Abebe F. Is interferon-gamma the right marker for bacille Calmette-Guérin-induced immune protection? The missing link in our understanding of tuberculosis immunology. Clin Exp Immunol 2012;169:213–19.
  • Doi T, Ando M, Akaike T, Suga M, Sato K, Maeda H. Resistance to nitric oxide in Mycobacterium avium complex and its implication in pathogenesis. Infect Immun 1993;61:1980–9.
  • Romero MM, Balboa L, Basile JI, Lopez B, Ritacco V, de la Barrera SS, et al. Clinical isolates of Mycobacterium tuberculosis differ in their ability to induce respiratory burst and apoptosis in neutrophils as a possible mechanism of immune escape. Clin Dev Immunol 2012;2012:152546.
  • Romero MM, Basile JI, Lopez B, Ritacco V, Barrera L, Sasiain Mdel C, et al. Outbreaks of Mycobacterium tuberculosis MDR strains differentially induce neutrophil respiratory burst involving lipid rafts, p38 MAPK and Syk. BMC Infect Dis 2014;14:262.
  • Sherkat R. Enigmas of primary immunodeficiency and mycobacterial infection in our territory. Allergy Asthma Clin Immunol 2014;10:A30–A.
  • de Oliveira-Junior EB, Bustamante J, Newburger PE, Condino-Neto A. The human NADPH oxidase: primary and secondary defects impairing the respiratory burst function and the microbicidal ability of phagocytes. Scand J Immunol 2011;73:420–7.
  • He H, Genovese KJ, Swaggerty CL, Nisbet DJ, Kogut MH. Differential induction of nitric oxide, degranulation, and oxidative burst activities in response to microbial agonist stimulations in monocytes and heterophils from young commercial turkeys. Vet Immunol Immunopathol 2008;123: 177–85.
  • Inderlied CB, Kemper CA, Bermudez LE. The Mycobacterium avium complex. Clin Microbiol Rev 1993;6: 266–310.
  • Mayer BK, Falkinham JO 3rd. Superoxide dismutase activity of Mycobacterium avium, M. intracellulare, and M. scrofulaceum. Infect Immun 1986;53:631–5.
  • Larijani B, Mossafa N, Shoshtarizadeh P, Nouraei M, Javadi E, Shafaei A-R, et al. Phagocyte respiratory burst activity in patients with type 2 diabetes, using PMA and FMLP stimuli. Iran J Diabetes Lipid Disorders 2003;2:53–7.
  • Osar Z, Samanci T, Demirel GY, Damci T, Ilkova H. Nicotinamide effects oxidative burst activity of neutrophils in patients with poorly controlled type 2 diabetes mellitus. Exp Diabesity Res 2004;5:155–62.
  • Segal MS, Shah R, Afzal A, Perrault CM, Chang K, Schuler A, et al. Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes 2006;55:102–9.
  • Bermudez LE, Young LS. Tumor necrosis factor, alone or in combination with IL-2, but not IFN-gamma, is associated with macrophage killing of Mycobacterium avium complex. J Immunol 1988;140:3006–13.
  • Appelberg R. Protective role of interferon gamma, tumor necrosis factor alpha and interleukin-6 in Mycobacterium tuberculosis and M. avium infections. Immunobiology 1994;191:520–5.
  • Eriks IS, Emerson CL. Temporal effect of tumor necrosis factor alpha on murine macrophages infected with Mycobacterium avium. Infect Immun 1997;65:2100–6.
  • Lee SJ, Ryu YJ, Lee JH, Chang JH, Shim SS. The impact of low subcutaneous fat in patients with nontuberculous mycobacterial lung disease. Lung 2014;192: 395–401.
  • Yuan X, Zhang T, Kawakami K, Zhu J, Zheng W, Li H, et al. Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China. BMC Infect Dis 2013; 13:315.
  • Ruegg TL, Kim EM, Simmons BA, Keasling JD, Singer SW, Soon Lee T, et al. An auto-inducible mechanism for ionic liquid resistance in microbial biofuel production. Nat Commun 2014;5:3490.
  • Argiris A, Maun N, Berliner N. Mycobacterium avium complex inclusions mimicking Gaucher's cells. N Engl J Med 1999;340:1372.
  • Baylor P, Larson R. Mycobacterium avium septicemia with ARDS in a patient with diabetes mellitus and no other known immune-compromising condition. J Intensive Care Med 2009;24:140–3.
  • Conejero R, Ara M, Lorda M, Rivera I. Mycobacterium chelonae infection in a patient being treated with adalimumab. Actas Dermosifiliogr 2012;103:69–71.
  • Halleran WJ, Martin NL. Nontuberculous mycobacterial arthritis: report of a chronic case. J Kans Med Soc 1982;83:284–6.
  • Nash KA, Inderlied CB. Genetic basis of macrolide resistance in Mycobacterium avium isolated from patients with disseminated disease. Antimicrob Agents Chemother 1995;39:2625–30.
  • Nash KA, Inderlied CB. Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. Antimicrob Agents Chemother 1996; 40:1748–50.